[1]CurrentPatentAssignee:QUEEN'SUNIVERSITYATKINGSTON-US2005/282840,2005,A1Locationinpatent:Page/Pagecolumn61
[1]Patent:US2008/249290,2008,A1.Locationinpatent:Page/Pagecolumn22
[1]Tetrahedron,2012,vol.68,p.8636-8644
[2]JournalofChemicalResearch,2012,vol.36,p.691-696
[3]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.4022-4026
[4]Patent:US2010/216853,2010,A1.Locationinpatent:Page/Pagecolumn19
[5]ChemistryandBiology,2010,vol.17,p.471-482
[1]CurrentPatentAssignee:WISTARINSTITUTE;THEJOHNSHOPKINSUNIVERSITY-US2010/216853,2010,A1Locationinpatent:Page/Pagecolumn20
[1]JournalofMedicinalChemistry,2017,vol.60,p.8055-8070
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: G M Antón-Fos, et al. Pharmacological Studies of the Two New Hypoglycaemic Compounds 4-(3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic Acid and 1-(mesitylen-2-sulfonyl)-1H-1,2,4-triazole. Arzneimittelforschung. 1994 Jul;44(7):821-6.